E. Tedaldi

发表

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Provider Compliance With Guidelines for Management of Cardiovascular Risk in HIV-Infected Patients

J. Chmiel, K. Lichtenstein, C. Armon, 2013, Preventing chronic disease.

Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.

D. Niewoehner, J. Connett, J. Vestbo, 2016, The Lancet. Respiratory medicine.

Ethnicity, Race, and Gender: Differences in Serious Adverse Events Among Participants in an Antiretroviral Initiation Trial: Results of CPCRA 058 (FIRST Study)

Avis J. Thomas, J. Absalon, M. van den Berg-Wolf, 2008, Journal of acquired immune deficiency syndromes.

Effect of IL‐2 on hepatitis C virus RNA levels in patients co‐infected with human immunodeficiency virus receiving HAART

N. Markowitz, E. Tedaldi, L. Chen, 2005, Journal of viral hepatitis.

Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000–2013

J. Chmiel, D. Ward, C. Armon, 2017, Open forum infectious diseases.

Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.

E. Tedaldi, F. Visnegarwala, Li Chen, 2005, The Journal of infection.

Emerging Therapies for Hepatitis C and HIV in Drug Abusers

E. Tedaldi, 2008, Journal of addictive diseases.

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

A. Mocroft, B. Clotet, V. Soriano, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.

K. H. Hullsiek, R. Arduino, E. Tedaldi, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New drug targets for HIV and hepatitis C virus coinfection.

E. Tedaldi, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.

Linda A. Battalora, D. Ward, C. Armon, 2019, AIDS.

Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center

Huaqing Zhao, E. Tedaldi, R. Samuel, 2020, Journal of the International Association of Providers of AIDS Care.

Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients.

M. van den Berg-Wolf, E. Tedaldi, 2009, The American journal of medicine.

Ezetimibe combined with low-dose statin effectively lowers LDL in protease inhibitor treated patients.

J. Gaughan, M. van den Berg-Wolf, E. Tedaldi, 2008, AIDS patient care and STDs.

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication

E. Gracely, L. Bachmann, E. Tedaldi, 2010, PloS one.

Weight Gain and Metabolic Effects in Persons With HIV Who Switch to ART Regimens Containing Integrase Inhibitors or Tenofovir Alafenamide

D. Ward, K. Buchacz, F. Palella, 2022, Journal of acquired immune deficiency syndromes.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Hyaluronic Acid Levels Predict Increased Risk of Non-Aids Death in Hepatitis-Coinfected Persons Interrupting Antiretroviral Therapy in the Smart Study

A. Mocroft, B. Clotet, V. Soriano, 2011, Antiviral therapy.

Impact of Age on Retention in Care and Viral Suppression

Richard D Moore, K. Anastos, A. Burchell, 2015, Journal of acquired immune deficiency syndromes.

Grade 4 Events Are as Important as AIDS Events in the Era of HAART

J. Neaton, W. Burman, E. Tedaldi, 2003, Journal of acquired immune deficiency syndromes.

Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

A. Mocroft, B. Clotet, J. Lundgren, 2010, AIDS.

Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.

R. Sterling, E. Tedaldi, P. Gaglio, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

A. Moorman, K. Wood, S. Holmberg, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients

K. Buchacz, A. Moorman, K. Wood, 2006, Journal of acquired immune deficiency syndromes.

Medical Consequences of Drug Abuse and Co-Occurring Infections

G. Treisman, J. Khalsa, E. McCance-Katz, 2008, Substance abuse.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

J. Ward, K. Buchacz, A. Moorman, 2011, Journal of viral hepatitis.

Virologic and immunologic response to HAART, by age and regimen class

B. Lau, S. Gange, M. Saag, 2010, AIDS.

CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.

T. Fischer-Smith, J. Rappaport, E. Tedaldi, 2008, AIDS research and human retroviruses.

HIV-Associated Neurocognitive Disorders: The Relationship of HIV Infection with Physical and Social Comorbidities

N. Minniti, E. Tedaldi, T. Fischer, 2015, BioMed research international.

Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

J. Karn, K. Khalili, R. Kamiński, 2015, Scientific Reports.

Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR / Cas 9 Gene Editing SUPPLEMENTARY MATERIALS

J. Karn, K. Khalili, R. Kamiński, 2016 .

Cardiovascular disease in patients with chronic human immunodeficiency virus infection.

A. Bove, E. Tedaldi, R. O. Escárcega, 2014, International journal of cardiology.

HIV and hepatitis in an urban penetrating trauma population: unrecognized and untreated.

J. Gaughan, M. Seamon, A. Pathak, 2011, The Journal of trauma.

Sleep disturbances in HIV-infected patients associated with depression and high risk of obstructive sleep apnea

C. Armon, K. Buchacz, E. Tedaldi, 2019, SAGE open medicine.

CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009

C. Armon, K. Buchacz, J. Brooks, 2011, AIDS research and treatment.

HIV RNA Suppression during and after Pregnancy among Women in the HIV Outpatient Study, 1996 to 2015

M. Lampe, C. Armon, K. Buchacz, 2018, Journal of the International Association of Providers of AIDS Care.

Longitudinal Changes in, and Factors Associated with, the Frequency of Condomless Sex Among People in Care for HIV Infection, HIV Outpatient Study USA, 2007–2019

Linda A. Battalora, D. Ward, C. Armon, 2022, AIDS and Behavior.

Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV‐coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals

A. Mocroft, J. Rockstroh, C. Boesecke, 2017, HIV medicine.

HCV RNA profiles among chronic HIV/HCV coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in 9 individuals

A. Mocroft, J. Rockstroh, C. Boesecke, 2016 .

Retention in Care within 1 Year of Initial HIV Care Visit in a Multisite US Cohort

J. Chmiel, K. Buchacz, J. Brooks, 2014, Journal of the International Association of Providers of AIDS Care.

HIV viral exposure and mortality in a multicenter ambulatory HIV adult cohort, United States, 1995–2016

Linda A. Battalora, S. Cole, C. Armon, 2021, Medicine.

Corrigendum: Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

J. Karn, K. Khalili, R. Kamiński, 2016, Scientific Reports.

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.

J. Chmiel, K. Lichtenstein, C. Armon, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk Factors and Incidence of Syphilis in Human Immunodeficiency Virus (HIV)–Infected Persons: The HIV Outpatient Study, 1999–2015

Linda A. Battalora, D. Ward, C. Armon, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The HIV Outpatient Study-25 Years of HIV Patient Care and Epidemiologic Research.

Linda A. Battalora, D. Ward, C. Armon, 2020, Open forum infectious diseases.

Pulmonary function in an international sample of HIV‐positive, treatment‐naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

D. Niewoehner, C. Kityo, E. Tedaldi, 2015, HIV medicine.

Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population

J. Chmiel, C. Armon, K. Buchacz, 2013, Journal of General Internal Medicine.

Rates of suicidal ideation among HIV-infected patients in care in the HIV Outpatient Study 2000-2017, USA.

C. Armon, K. Buchacz, F. Palella, 2020, Preventive medicine.

Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States.

K. Buchacz, K. Wood, J. Brooks, 2012, AIDS patient care and STDs.

Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us

J. Chmiel, K. Lichtenstein, K. Buchacz, 2012, Antiviral therapy.

Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus.

E. Tedaldi, S. Willard, P. Axelrod, 2002, The Journal of the Association of Nurses in AIDS Care : JANAC.

Nice to your heart: A pilot community-based intervention to improve heart health behaviours in urban residents

F. Patterson, E. Tedaldi, Laurie Maurer, 2016 .

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment

J. Chmiel, K. Buchacz, J. Brooks, 2011, AIDS.

Use of dupilumab in patients who are HIV‐positive: report of four cases

K. Savage, E. Tedaldi, N. Mollanazar, 2019, British Journal of Dermatology.

A Randomized Trial of Educational Materials , Pillboxes , and Mailings to Improve Adherence with Antiretroviral Therapy in an Inner City HIV Clinic

Mary van den Berg-Wolf, E. Tedaldi, P. Axelrod, 2006 .

Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015

C. Armon, K. Buchacz, F. Palella, 2018, PloS one.

Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.

Avis J. Thomas, J. Absalon, T. Giordano, 2010, AIDS Patients Care and STDs.

A heavy burden: preexisting physical and psychiatric comorbidities, and differential increases among male and female participants after initiating antiretroviral therapy in the HIV Outpatient Study, 2008-2018.

C. Armon, K. Buchacz, F. Palella, 2022, AIDS research and human retroviruses.

Hepatitis C Virus Testing Among Men With Human Immunodeficiency Virus Who Have Sex With Men: Temporal Trends and Racial/Ethnic Disparities.

C. Armon, K. Buchacz, F. Palella, 2021, Open forum infectious diseases.

Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.

Linda A. Battalora, D. Ward, C. Armon, 2019 .

Disparities in HIV Viral Load Suppression by Race/ethnicity among Men who Have Sex with Men in the HIV Outpatient Study.

D. Ward, C. Armon, K. Buchacz, 2018, AIDS research and human retroviruses.

Time spent with HIV viral load above 1500 copies/ml among patients in HIV care, 2000-2014.

C. Armon, K. Buchacz, L. Gardner, 2018, AIDS.

Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients

Sarah Bauerle Bass, S. Bass, J. Greener, 2016, AIDS care.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Minority HIV patients' perceptions of barriers and facilitators to participation in clinical research.

S. Bass, E. Tedaldi, Caitlin Wolak, 2012, Current HIV Research.

Correction: Trends of racial and ethnic disparities in virologic suppression among women in the HIV Outpatient Study, USA, 2010-2015

C. Armon, K. Buchacz, F. Palella, 2018, PloS one.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

T. Harrer, A. Winston, E. Harrer, 2023, Scientific Reports.

Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018.

K. Buchacz, F. Palella, Jun Li, 2021, AIDS patient care and STDs.

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.

K. Lichtenstein, C. Armon, K. Buchacz, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.

Ethnicity, Race, and Gender: Differences in Serious Adverse Events Among Participants in an Antiretroviral Initiation Trial: Results of CPCRA 058 (FIRST Study)

Avis J. Thomas, J. Absalon, M. van den Berg-Wolf, 2008, Journal of acquired immune deficiency syndromes.

Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.

K. H. Hullsiek, R. Arduino, E. Tedaldi, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

A. Mocroft, B. Clotet, V. Soriano, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

K. Buchacz, A. Moorman, J. Brooks, 2011, Journal of viral hepatitis.

Acute asthma. I. A comparison of the immediate effects of six different modes of therapy.

R. C. Meyer, E. Tedaldi, R. Brandstetter, 1974 .

Virologic and immunologic response to HAART, by age and regimen class

B. Lau, S. Gange, M. Saag, 2010, AIDS.

Impact of Age on Retention in Care and Viral Suppression

K. Anastos, A. Burchell, M. Gill, 2015, Journal of acquired immune deficiency syndromes.

Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021

K. Buchacz, F. Palella, J. Mahnken, 2023, AIDS research and treatment.

Emerging Therapies for Hepatitis C and HIV in Drug Abusers

E. Tedaldi, 2008, Journal of addictive diseases.